Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sriam Labs is an Indian pharmaceutical company that specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced drug intermediates. As a wholly-owned subsidiary of Laurus Labs, the company provides comprehensive Contract Development and Manufacturing Organization (CDMO) services to the global life sciences industry. Its expertise lies in small molecule chemistry, supporting therapeutic areas such as antiretrovirals, oncology, cardiovascular, and central nervous system disorders. Sriam Labs operates manufacturing facilities that adhere to international quality standards, including GMP. The company serves as a strategic manufacturing arm, enabling the production of complex chemical entities for both generic and innovator pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sriam Labs.